PI-LAB-2026-164

Liraglutide, Independent Lab Report

Liraglutide 18mg · Quantum Peptide Group

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.6% met the stated ≥98% claim. Content measured 99.5% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.6%

Label claimed ≥98%

Content accuracy
99.5%

17.91mg measured against 18mg claimed

Test recency
Current cycle

Published 7 months ago

Specimen PI-LAB-2026-164 Tested by Chelsea Analytical Group 12 samples tested from this company Purity & Testing score 98/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.6% Within analytical tolerance
Identity (MS) Liraglutide Confirmed Matches label
Content 18 mg 17.91 mg Within 5% of label

Methodology & chain of custody

Quantitative amino acid analysis against certified reference standard.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
B3178-26
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2026-164-report.pdf (document delivery arrives with the production storage backend)

More Tests, Quantum Peptide Group

BPC-157
Purity 97.1% Verified
Tirzepatide
Purity 97.8% Verified
Exenatide
Purity 98.5% Verified

More Tests, Liraglutide

Liraglutide Cardinal Metabolic Clinic
Purity 97.8% Verified
Liraglutide NextGen Peptides
Purity 97.3% Verified
Liraglutide Helix Research Supply
Purity 97.7% Verified